A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354
NCT00638989
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Healthy
Interventions
BIOLOGICAL:
CAT-354 150 mg (intravenous)
BIOLOGICAL:
CAT-354 150 mg (subcutaneous)
BIOLOGICAL:
CAT-354 300 mg (subcutaneous)
Sponsor
MedImmune LLC